Wegovy is approved to help manage weight loss
As of 2025, a total of 81 clinical trials have been initiated in this area, with four of them having been withdrawn
Thus, careful monitoring during the first weeks of GLP-1 therapy is critical
100 A recent Phase 2b trial in obese individuals demonstrated that 32 weeks of treatment with danuglipron at doses ranging from 40 to 200 mg twice daily resulted in an average weight loss of 11.7%, whereas the placebo group exhibited 1.4% weight gain
But the results from animal models are consistent enough that many integrative vets have started using it off-label, and anecdotal reports from dog owners are stacking up
While the precise nature of the priming event at S114 remains unclear, our findings demonstrate that the casein kinase ortholog, KIN-19, is capable of phosphorylating adjacent serine residues in the hinge region of NHR-49